The NF-κB/NLRP3 pathway plays a central role in inflammation-related diseases, including gouty arthritis, and the blockade of the NF-κB/NLRP3 pathway is now proven to be an effective strategy to prevent and ameliorate AGA [34, 35]. This evidence concerns the gene NLRP3 and gout.